Recomienda este artículo a tus amigos:
Generic Drugs: Guidelines for Bioequivalence Studies Pushpendra Kumar Vishwakarma
Generic Drugs: Guidelines for Bioequivalence Studies
Pushpendra Kumar Vishwakarma
A generic drug (generic drugs, short: generics) is a drug which is produced and distributed without patent protection. The generic drug may still have a patent on the formulation but not on the active ingredient. A generic must contain the same active ingredients as the original formulation. According to the U. S. Food and Drug Administration (FDA), generic drugs are identical or bioequivalent to the brand name counterpart with respect to pharmacokinetic and pharmacodynamic properties. By extension, therefore, generics are identical in dose, strength, route of administration, safety, efficacy, and intended use. In most cases, generic products are available once the patent protections afforded to the original developer have expired. When generic products become available, the market competition often leads to substantially lower prices for both the original brand name product and the generic forms. The time it takes a generic drug to appear on the market varies.
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 2 de junio de 2011 |
| ISBN13 | 9783639343779 |
| Editores | VDM Verlag Dr. Müller |
| Páginas | 148 |
| Dimensiones | 150 × 9 × 226 mm · 226 g |
| Lengua | Inglés |
Mas por Pushpendra Kumar Vishwakarma
Mostrar todoMere med samme udgiver
Ver todo de Pushpendra Kumar Vishwakarma ( Ej. Paperback Book )